Vir Biotechnology, Inc. · NASDAQ:VIR
Vir Biotechnology, Inc. shareholders
As of Jun 30, 2026, 229 institutions reported holding Vir Biotechnology, Inc., 86.6% of its shares. Largest: BlackRock, Vanguard and ARCH Venture Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Vir Biotechnology, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 20.7M | 12.2% | +2.68M | Aug 7, 2026 |
| Vanguard | 18.9M | 11.2% | +3.4M | Aug 13, 2026 |
| ARCH Venture Management, LLC | 12.7M | 7.5% | −223K | Aug 14, 2026 |
| Sb Investment Advisers (UK) LTD | 10.9M | 6.5% | no change | Aug 14, 2026 |
| State Street | 9.96M | 5.9% | +2.82M | Aug 7, 2026 |
| GSK plc | 8.55M | 5.1% | no change | Aug 13, 2026 |
| Point72 Asset Management, L.P. | 5.67M | 3.3% | +3.71M | Aug 14, 2026 |
| Geode Capital | 3.35M | 2.0% | +691K | Aug 12, 2026 |
| Dimensional | 3.12M | 1.8% | +540K | Aug 11, 2026 |
| ADAR1 Capital Management, LLC | 2.46M | 1.5% | −288K | Aug 14, 2026 |